Skip to main content
Watch Insiders

Corporate insider profile

Christopher Thomas Giordano Insider Trades

Latest reported as CEO of TENAX THERAPEUTICS, INC. (TENX).

Purchase filings
1
Reported companies
1
Net open-market value
$20,088
Latest transaction
Sep 15, 2026

Affiliated corporations

Reported company relationships

TENXLatest reported

TENAX THERAPEUTICS, INC.

CEO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 15, 2026TENAX THERAPEUTICS, INC. (TENX)CEOOpen Market Purchase10,850$1.85$20,088